Wellis Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: flat-rate compounded semaglutide and tirzepatide with the consult and shipping included
Wellis scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Wellis is a telehealth brand on the tgdcare.com network, run by TagadaPay LLC in Houston, that offers compounded semaglutide and tirzepatide through clinicians with MDI Medical Group. Semaglutide is $199 a month and tirzepatide is $249 a month, the same price at every dose, with the clinician consultation and shipping included. Your card is held at checkout and only charged if a clinician prescribes. It also offers hair-loss and ED treatment.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Wellis
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Wellis at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Wellis
Each dimension is scored algorithmically from Wellis’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.1/10At $199/mo, Wellis runs about 9% above the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.0/10Wellis offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience (consult included in the price); 7 platform features disclosed.
Trust & Safety15%
8.0/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.2/10Wellis treats patients in all 50 states.
Support10%
5.8/10Wellis provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Wellis review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $199–$249/mo across 2 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Wellis
We walked Wellis’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1'Begin consultation' on the weight-loss card opens a welcome screen that says the questions take 2 to 3 minutes
- 2The first question asks your weight-loss goal, the first of four short intake questions
- 3Wellis says a licensed clinician reviews your answers within 24 hours, and a video or phone visit may be needed depending on your state
- 4A hold is placed on your card at checkout, and you are only charged if the clinician prescribes
- Both GLP-1 prices are on the homepage and in the FAQ before you answer any questions
- The FAQ says the price is the same at every dose and covers the consultation, medication and shipping
- Wellis is part of the tgdcare.com network, so emails and your card statement show the tgdcare name
- The pharmacy is described only as a licensed U.S. pharmacy and is not named
Wellis customer support
GLP-1 medications Wellis offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$199 billed at checkout, then on or around each refill's ship date (typically every 30 days); includes the clinician consultation and shipping.
$249 billed at checkout, then on or around each refill's ship date (typically every 30 days); includes the clinician consultation and shipping.
Ready to get started?
Plans and promotions change often, so check Wellis's current pricing and active discounts before you decide.
What we like
- Prices are on the homepage before you start: $199 for semaglutide and $249 for tirzepatide
- Same price at every dose, with the clinician consultation and shipping included
- Your card is only charged if a clinician prescribes; otherwise the hold is released
- Names its medical group, MDI Medical Group PC, in its terms
- LegitScript seal served from LegitScript's own site for the tgdcare.com network it runs on
- Cancel anytime from your account or by email, with no cancellation fees
Watch-outs
- It does not name the pharmacy that fills prescriptions, only a licensed U.S. pharmacy
- Support is by email and the patient portal, with no phone line
- Plans renew automatically, billed around each refill's ship date, typically every 30 days
- Shipped medication is non-refundable, and consultation fees can't be refunded once review begins
- Its Trustpilot page is unclaimed with no reviews yet
- Your card statement shows TGDCARE rather than Wellis
- Disputes go to binding individual arbitration in Harris County, Texas, unless you opt out within 30 days
Is Wellis worth it?
The short version of what Wellis offers is flat-rate compounded semaglutide and tirzepatide with the consult and shipping included. It runs $199/month at every dose, squarely in the middle of what this category charges, so what you get for it matters more here than the number itself. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
On top of the core program, it is LegitScript-certified and charges the same price at every dose.
How much Wellis costs
Compounded semaglutide runs $199/month and compounded tirzepatide runs $249/month.
That's roughly in line with the ~$182/month median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide).
For a direct comparison, Brightmeds runs semaglutide and tirzepatide from $189/month, so compare it with Wellis before you commit.
Medications: what Wellis prescribes
Wellis prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Wellis is best for, and who should skip it
A good fit if you…
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Wellis treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Wellis is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Belle Health is one of the closest alternatives we track; compare the two before deciding.
The Bottom Line
Wellis scores highest on state availability and ease of access.
Ready to start with Wellis?
From $199/mo. See current pricing and start your free consultation.
Wellis might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Wellis vs…
Wellis scores7.5/10
Side-by-side pricing, medications and scores. Pick a matchup.
Wellis vs Amazon One Medical
Amazon One Medical scores 8.5/10

Wellis vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Wellis review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Wellis's current pricing
Plans from $199/mo. Start your free consultation to check eligibility and today's price.